I did wubing...
"It is making plans to submit its CE Mark application for
pancreatic cancer and also in liver cancer indications, which
it aims to do in the coming weeks."
You can kiss Q3 approval goodbye, they haven't even sent the application letter yet. You'd think they'd be well drilled at that... but no, the new group is slacker than the old.
Something is brewing alright... the company will apply once again for the umpteenth time and the EMA and FDA will reject them again.
Doesn't it ever bore you wubing?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |